Physician profile
Robert J Hirsch
NPI 1376545996
$235.50
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $31.10.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $64.91 | 2019 | |
| Avion Pharmaceuticals | $34.94 | 2019-2020 | |
| Millicent US INC | $33.46 | 2019-2020 | |
| Abbvie INC. | $29.33 | 2019 | |
| Mission Pharmacal Company | $18.59 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.53 | 2019 | |
| Therapeuticsmd, INC. | $14.34 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.07 | 2019 | |
| Pfizer INC. | $12.33 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.